There’s an interesting study on Ephedra—aka herbal fen-phen—called “The Relative Safety of Ephedra Compared with Other Herbal Products” by S. Bent, TN Tiedt, MC Odden and MG Shlipak. It was published in the Annals of Internal Medicine (3/18/03, volume 138, pp. 468-471).
In the study, the researchers looked at the number of adverse effects reported to US poison control centers during 2001. Keep in mind, the study is now a few years old as Ephedra has been banned since 2004. But the study was conducted during the time in which Ephedra was still riding high in popularity as a diet supplement.
The results of the study showed:
Products containing ephedra accounted for 64% of all reported adverse effects from herbs even though they represented less than 1% of total herbal product sales. The risk for an adverse effect from ephedra compared with other commonly used herbal products was very high. For example, relative risks for adverse effects from ephedra were 100 times greater than from kava and as much as 700 times greater than from Ginkgo biloba. Types and severity of adverse effects were not described. Read the rest of this entry »